GENE ONLINE|News &
Opinion
Blog

Ruchi Jhonsa

WRITTEN BY Ruchi Jhonsa

Precision Oncology: Overview of Diagnostic Technologies
2021-05-25
Pfizer Expands in Infectious Disease Market with Amplyx’s Acquisition
2021-05-03
Arch Oncology Secures $105 Million in Funding for Advancing Anti-CD47 Therapy
2021-04-29
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
DiaCarta Unveils a Rapid, Highly Specific Technology to Detect COVID-19 Variants
2021-04-23
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
How Liquid Biopsies are Helping in Detection of Cancer Relapse?
2021-04-17
New Strategies to Improve Adoptive Cell Therapies for Solid Tumors
2021-04-14
Sanofi to Go After mRNA Based Cancer Treatments, Acquires Cambridge Startup for $470 Million
2021-04-12
Immunocore’s Bispecific Cancer Therapy Impresses in Eye Cancer Trial
2021-04-10
Acadia Fumes Over FDA Rejection of its Psychosis Drug Nuplazid
2021-04-06
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
uniQure’s Inquiry Shows Hemophilia B Gene Therapy not Likely to Have Induced Liver Cancer
2021-03-30
10 Top Gene Therapy Companies in 2021
2021-03-26
Genentech Seeks FDA’s Blessings after Adjuvant Tecentriq Shows Promising Result in Lung Cancer Patients
2021-03-23
1 2 3 13
Scroll to Top